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Abstract
MicroRNAs (miRNAs) are a newly discovered type of small non-protein coding RNA that function in the inhibition
of effective mRNA translation, and may serve as susceptibility genes for various disease developments. The SNP
rs12416605, located in human type 1 diabetes IDDM10 locus, changes the seeding sequence (UGU[G/A]CCC) of
miRNA miR-938 and potentially alters miR-938 targets, including IL-16 and IL-17A. In an attempt to test whether
miR-938 may be a susceptibility gene for IDDM10, we assessed the possible association of the miR-938 SNP with
T1D in an American Caucasian cohort of 622 patients and 723 healthy controls by TaqMan assay. Our current data
do not support the association between the SNP in miR-938 and type 1 diabetes.
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To the Editor
In recent years, it has become evident that the tradi-
tional central dogma of DNA transcription into messen-
ger RNA (mRNA) and mRNA translation into proteins
describes only a part of the genetic information machin-
ery that determines which proteins might possibly be
synthesized. Additional genetic information is required
to control the timing and rates of protein manufacturing
processes. Although only a minority of the human gen-
ome (2-3%) codes for proteins, a large fraction of the
non-protein coding genome is transcribed. MicroRNAs
(miRNAs) are a newly discovered type of small non-pro-
tein coding RNAs (21-25nt) that function in the inhibi-
tion of effective mRNA translation through imperfectly
base pairing with the 3’ untranslated region (3’-UTR) of
target mRNAs. miRNA targets are largely unknown but
they are thought to target about 30%-80% of total
human proteins at a frequency of about one to hun-
dreds of target genes for a given miRNA. Previous stu-
dies indicate that miRNAs play a very important role in
determining cellular development, apoptosis, differentia-
tion, and proliferation. Recent studies from our group
and others have reported that miRNAs are involved in
immune cell development, including CD4
+CD25
+FoxP3
+
regulatory T cells and natural killer T cells. Further-
more, mice without expression of miRNAs in the bone
marrow and the thymus develop autoimmune diseases
[1,2]. Most importantly, miRNAs as susceptibility genes
contribute to various disease developments, including
cancer [3]. Human type 1 diabetes (T1D), or insulin-
dependent diabetes mellitus (IDDM), is clearly a chronic
autoimmune disorder caused by the interaction of envir-
onmental factors with an inherited predisposition. To
date, about 50 IDDM susceptibility loci have been
mapped to specific chromosome regions in the human.
A long search for the gene(s) responsible for diabetes
susceptibility has identified only very few candidate
genes in past decades. This raises the possibility that the
candidate search is a much more complex process than
initially assumed, or that some non-coding regulatory
genes were missed in previous studies. Given miRNA’s
suppressive nature and critical role in regulation, the
possibility that miRNAs are T1D-risk genes may under-
lie the diverse findings of genetic studies, including evi-
dence that protein altering gene polymorphisms are not
generally found in T1D. Mutations located in critical
areas of the mature miRNA potentially affect its struc-
ture or expression level, which may lead to abnormal
protein-coded gene expression that is phenotypically
similar to the disruption of the protein-coded gene itself.
Thus, inadequate or miss-timed expression of a func-
tional protein may occur either due to disruption of the
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tein, or due to abnormal miRNA regulation of a normal
gene. To date there is no direct evidence linking miR-
NAs and human T1D susceptibility. We previously
mapped 27 miRNAs located in 9 T1D susceptibility
regions [4], which places miRNAs as candidates for T1D
susceptibility genes. Here, using available single nucleo-
tide polymorphism (SNP) data bases, we found the SNP
rs12416605 in IDDM10 is located in the seeding
sequence (UGU[G/A]CCC) of miR-938, which changes
miR-938 targets. Most interestingly, inflammatory cyto-
kines IL-16 and IL-17A are potential targets of miR-938
based on miRNA targetscan analysis (http://www.tar-
getscan.org), and IL-16 and IL-17A may be involved in
T1D development [5,6]. Thus, the mutation in the miR-
938 seed sequence makes miR-938 unable to suppress
IL-16 and IL-17 expression and may enhance IL-16 and
IL-17 production in T1D patients.
IDDM10 is located in a 23Mb region on chromo-
some 10p12-q11, and the susceptibility gene for
IDDM10 is still currently unclear [7]. The potentially
functional relevance of miR-938 makes the miR-938
SNP a very attractive candidate mutation in IDDM10.
We hypothesized that miR-938 may be a susceptibility
gene for IDDM10. In an attempt to test this, we
assessed the possible association of the miR-938 SNP
with T1D in an American Caucasian population. The
study population consists of T1D patients and healthy
controls from Georgia. The data set includes 622
patients and 723 controls. All diabetic patients were
diagnosed using the criteria of the American Diabetes
Association. These patients and control subjects have
been used in the previous genetic studies [8]. The SNP
was genotyped using the TaqMan-assay method [8].
The assay (primers and probe) used in this study was
designed and validated by Applied Biosystems. Amplifi-
cation reactions were performed in a 5ul final volume
in optical 384-well plates. PCR was carried out with 2
min at 50°C, 10 min at 95°C followed by 40 cycles of
15 s at 95°C and 1 min at 60°C using an ABI9700 real-
time PCR system (Applied Biosystems). The genotypic
frequencies for the miR-938 SNP are presented in
Table 1. The control and patient populations were
found to be in Hardy-Weinberg equilibrium (P > 0.05).
The frequencies for the miR-938 genotypes and alleles
(Table 1) were similar between T1D patients and con-
trol subjects (P > 0.05). Our data from our Georgia
sample, therefore, do not support the association
between miR-938 and type 1 diabetes. Recently accu-
mulated genetic studies suggest that genetic heteroge-
neity or different linkage disequilibrium patterns are
responsible for the discrepancies observed in Cauca-
sians T1D. Thus, further studies, including functional
relevance of the miR-938 SNP and associations
observed in case/control studies in other populations,
need to be performed.
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